Correcting serum phosphate homeostasis does not alleviate the health dangers of high phosphate consumption
- 1The Atlanta Department of Veterans Affairs Medical Center
- 2Department of Medicine, Division of Endocrinology, Emory University
Abstract
Background It is widely recognized that dysregulated mineral balance, in the context of disease, has negative health consequences. However, growing evidence shows that imbalances in mineral homeostasis from a sustained high dietary intake of inorganic phosphate/phosphorus (Pi), even when kidney function remains clinically normal, can also cause serious health problems, including bone disease. Western-style diets, which commonly include added Pi salts, contribute significantly to the issue. Despite this, investigations into therapeutic strategies to counter these effects in the absences of disease are limited. This study aimed to determine whether clinically used pharmacologic and nutritional interventions could regulate mineral homeostasis and prevent bone loss while correcting the systemic consequences of chronic high dietary Pi intake. Methods Healthy mice were fed diets with high (HPD), normal (NPD), or low (LPD) levels of Pi additives and constant calcium (Ca). Additional groups were treated with HPD and supplemented with Vitamin D, Lanthanum Carbonate, Cinacalcet, Zoledronic acid, or a strategy of balancing dietary Ca:Pi. Results The therapies that partially or fully corrected serum Pi levels and homeostatic factors, interestingly, corrected the increase in cortical porosity but did not correct the HPD-induced decrease in cortical or trabecular bone volume. Only Zoledronic acid successfully restored the bone volume lost due to HPD but exacerbated the HPD increase in cortical porosity. Surprisingly, many of the treatments generated an inflammatory response in kidney in the context of HPD, suggesting that they can have harmful side effects in the absence of overt kidney disease. Conclusions This work advances the understanding of the health impacts of Pi additives which are common in ultra-processed foods and common in the Western style diet. Specifically, the results produce clinically relevant findings that simply controlling serum Pi and/or Ca levels or Pi responsive endocrine factors such as FGF23, PTH, and osteopontin are not sufficient to block the negative impacts of chronic high dietary Pi consumption on the skeleton. Further, therapeutic strategies to control serum Pi have an impact on the kidneys in the context of high dietary Pi intake.
Related
- Associations of serum phosphate levels and intravenous phosphate exposure with mortality in patients with sepsis: a multi-database retrospective study
- TMEM174 deficiency reduces longevity by promoting phosphate-driven vascular calcification
- Assessment of Vitamin D Status and Calcium–Phosphate Metabolism in Patients with Hypophosphatasia—A Single-Center Cohort Study
- Revealing the toxicological effects and mechanisms of tris(1-chloro-2-propyl) phosphate exposure on osteoarthritis based on network toxicology, machine learning, and molecular docking
- Laboratory-based case finding using phosphate and alkaline phosphatase to identify genetic and nutritional rickets in children
BibTeX
@article{arnst2026correcting,
title = {{Correcting serum phosphate homeostasis does not alleviate the health dangers of high phosphate consumption}},
author = {Jamie L. Arnst and Uma D. Alappan and Manjula Viggeswarapu and George R. Beck},
journal = {Journal of Translational Medicine},
year = {2026},
month = jul,
doi = {10.1186/s12967-026-08624-x},
url = {https://doi.org/10.1186/s12967-026-08624-x},
note = {CC BY},
}
RIS
TY - JOUR
TI - Correcting serum phosphate homeostasis does not alleviate the health dangers of high phosphate consumption
AU - Jamie L. Arnst
AU - Uma D. Alappan
AU - Manjula Viggeswarapu
AU - George R. Beck
PY - 2026
DA - 2026/07/01
JO - Journal of Translational Medicine
DO - 10.1186/s12967-026-08624-x
UR - https://doi.org/10.1186/s12967-026-08624-x
AB - Background It is widely recognized that dysregulated mineral balance, in the context of disease, has negative health consequences. However, growing evidence shows that imbalances in mineral homeostasis from a sustained high dietary intake of inorganic phosphate/phosphorus (Pi), even when kidney function remains clinically normal, can also cause serious health problems, including bone disease. Western-style diets, which commonly include added Pi salts, contribute significantly to the issue. Despite this, investigations into therapeutic strategies to counter these effects in the absences of disease are limited. This study aimed to determine whether clinically used pharmacologic and nutritional interventions could regulate mineral homeostasis and prevent bone loss while correcting the systemic consequences of chronic high dietary Pi intake. Methods Healthy mice were fed diets with high (HPD), normal (NPD), or low (LPD) levels of Pi additives and constant calcium (Ca). Additional groups were treated with HPD and supplemented with Vitamin D, Lanthanum Carbonate, Cinacalcet, Zoledronic acid, or a strategy of balancing dietary Ca:Pi. Results The therapies that partially or fully corrected serum Pi levels and homeostatic factors, interestingly, corrected the increase in cortical porosity but did not correct the HPD-induced decrease in cortical or trabecular bone volume. Only Zoledronic acid successfully restored the bone volume lost due to HPD but exacerbated the HPD increase in cortical porosity. Surprisingly, many of the treatments generated an inflammatory response in kidney in the context of HPD, suggesting that they can have harmful side effects in the absence of overt kidney disease. Conclusions This work advances the understanding of the health impacts of Pi additives which are common in ultra-processed foods and common in the Western style diet. Specifically, the results produce clinically relevant findings that simply controlling serum Pi and/or Ca levels or Pi responsive endocrine factors such as FGF23, PTH, and osteopontin are not sufficient to block the negative impacts of chronic high dietary Pi consumption on the skeleton. Further, therapeutic strategies to control serum Pi have an impact on the kidneys in the context of high dietary Pi intake.
SN - 1479-5876
ER -